Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
J2 Ventures is a venture capital firm based in the United States, dedicated to supporting early-stage companies in various technology sectors. The firm comprises a diverse team of investors, including PhD scientists, combat veterans, practicing physicians, and successful entrepreneurs. They maintain a portfolio of 8 companies, focusing on impactful technologies.
J2 Ventures invests in Seed and Series A rounds, targeting companies in advanced computing, biomedical engineering, cybersecurity, and infrastructure. They prioritize investments that align with their values and have the potential to create significant impact in national security and technology innovation.
Notable portfolio companies include Aalyria, which provides laser-fast internet at planetary scale; Acalvio, known for deception and identification technologies; Aether, focusing on human and machine teamed prosthetics; Apex Space, engaged in next-generation satellite manufacturing; Cinder, offering a unified intelligence platform for trust and safety; Femtosense, specializing in hyper-efficient computing for Edge AI; Micron Biomedical, innovating needle-free injection technologies; and SkyFi, operating the world's first satellite imagery marketplace.
Submit your pitch through their form at j2vp.com.
Yes, J2 Ventures often leads Seed and Series A rounds, providing initial capital and strategic guidance to startups.
J2 Ventures is open to follow-on investments, particularly in companies that demonstrate strong growth and alignment with their investment thesis.
Specific details about the fund size are not disclosed, but J2 Ventures focuses on early-stage investments in impactful technologies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.